ChemoTech expects to sign three new commercial contracts in Q4-2023, in addition to the three already communicated, thereby pushing the previous stated target of 15 commercial contracts in
The reason for postponing the goal of 15 commercial installations in
"The discussions and contract signings are taking somewhat longer due to this external event, but is by no means affected in terms of how they are progressing. We have not lost one single account in our discussions so far and foresee to have them completed in the first quarter of next year", says
ChemoTech continues to make strong progress in discussions with Indian hospitals and the company's commercial and clinical teams have presented at three tumour board meetings with around 30 oncology experts during the last two months. ChemoTech has also started discussions with leading cancer institutes in
For further information please contact:
Phone: +46 (0)10-218 93 00
E-mail: ir@chemotech.se
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on
ChemoTech is a Swedish medical technology company based in
https://news.cision.com/chemotech/r/scandinavian-chemotech-push-forward-previously-communicated-target-of-15-commercial-installations-in,c3891500
https://mb.cision.com/Main/14967/3891500/2485216.pdf
(c) 2023 Cision. All rights reserved., source